Fri, March 17, 2023
Thu, March 16, 2023
Wed, March 15, 2023
Tue, March 14, 2023
Mon, March 13, 2023
Fri, March 10, 2023
Thu, March 9, 2023

Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, Mar 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-mar-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $50 on, Mar 14th, 2023.

Andrew has made no other calls on AMLX in the last 4 months.



There is 1 other peer that has a rating on AMLX. Out of the 1 peers that are also analyzing AMLX, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $50 on, Thursday, January 5th, 2023

Publication Contributing Sources